Sermonix Pharmaceuticals

About:

Sermonix Pharmaceuticals is an Ohio LLC specialty pharmaceutical.

Top Investors: Perceptive Advisors, Richard DeSchutter, WILD Family Office, Anthony Wild, Lodewijk de Vink

Description:

Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company, focuses on the development and commercialization of late-stage women’s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 and is headquartered in Columbus, Ohio.

Total Funding Amount:

$67.6M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Columbus, Ohio, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)sermonixpharma.com

Founders:

David Portman

Number of Employees:

11-50

Last Funding Date:

2021-11-15

IPO Status:

Private

Industries: